REZUROCK

Международный товарный знак №1581984 REZUROCK
Номер регистрации: 1581984 Дата регистрации: 23.01.2021Базовая заявка:US, 24.07.2020, 90071349 Дата истечения срока действия регистрации:23.01.2031
Правообладатель: Kadmon Pharmaceuticals, LLC  119 Commonwealth Drive  Warrendale PA 15086  (US)Представитель:Michael J. Leonard Fox Rothschild LLP  997 Lenox Drive, Bldg. 3  Lawrenceville NJ 08648-2311  (US)
Венская классификация:26.11.02; 26.11.12; 27.05.01
Классы МКТУ и перечень товаров и/или услуг:055 - Pharmaceuticals and pharmaceutical preparations, namely, anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease.